The evaluation of human epidermal growth HER2 ((growth factor receptor 2) scoring by pathologists plays a crucial role in the diagnosis, prognosis, and treatment of breast cancer and other malignancies. HER2 is a protein involved in cell growth and division, and its overexpression is associated with more aggressive tumors and poorer outcomes in some cancer types.
HER2 by Tribun V 1.0 is a softwarebased in vitro medical device that utilizes artificial intelligence to support pathologists in scoring HER2 biomarker in invasive breast cancer.
This algorithm is an integral part of Tribun Health’s end-to-end AI-powered digital pathology platform to support cancer diagnosis. Our award-winning platform is designed to seamlessly run algorithms in its AI Apps suite.
Step 1
Step 2
Step 3
Step 4
Tribun Health’s HER2 algorithm supports the analysis of HER2 images and streamlining the scoring process in invasive breast cancer. By doing so, it assists pathologists in providing more precise and timely results used to establish a diagnosis.
Explore Tribun Health's all-encompassing platform, featuring our diverse modules: MacroCam, CaloPix® Archive, AI Apps, CaloPix®, and TeleSlide® Patho. Designed to fulfill the digitization requirements of pathology departments, these modules seamlessly integrate into pathologists' workflows. At the core of the digital pathology process lies our Image Management System (IMS), CaloPix®.
.png?width=256&height=256&name=customer-service(1).png)
.png?width=64&height=64&name=calendrier(1).png)
.png?width=64&height=64&name=communique-de-presse(1).png)
.png?width=64&height=64&name=livre(1).png)
.png?width=64&height=64&name=blog(2).png)
